BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35436363)

  • 1. Single-cell transcriptomic analysis reveals circadian rhythm disruption associated with poor prognosis and drug-resistance in lung adenocarcinoma.
    He L; Fan Y; Zhang Y; Tu T; Zhang Q; Yuan F; Cheng C
    J Pineal Res; 2022 Aug; 73(1):e12803. PubMed ID: 35436363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined analysis of single-cell and bulk RNA sequencing reveals the expression patterns of circadian rhythm disruption in the immune microenvironment of Alzheimer's disease.
    He H; Yang Y; Wang L; Guo Z; Ye L; Ou-Yang W; Yang M
    Front Immunol; 2023; 14():1182307. PubMed ID: 37251379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Bulk and Single-Cell RNA-Sequencing Reveals the Effects of Circadian Rhythm Disruption on the Metabolic Reprogramming of CD4+ T Cells in Alzheimer's Disease.
    Weng W; Fu J; Cheng F; Wang Y; Zhang J
    Mol Neurobiol; 2024 Jan; ():. PubMed ID: 38265551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subtypes of ischemic heart disease based on circadian rhythm.
    Zhou Z; Zhang G; Wang Z; Xu Y; Qin H; Zhang H; Zhang P; Li Z; Xu S; Tan X; Zeng Y; Yu F; Zhu S; Chang L; Zheng Y; Han X
    Sci Rep; 2024 Jun; 14(1):14155. PubMed ID: 38898215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis indicates the prognostic value of circadian rhythm disruption in liver cancer: Potential for therapeutic targeting.
    Wang RQ; Cui W; Cai J; Sun Y
    Front Immunol; 2022; 13():1011264. PubMed ID: 36569894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant R-loop-mediated immune evasion, cellular communication, and metabolic reprogramming affect cancer progression: a single-cell analysis.
    Zhang S; Liu Y; Sun Y; Liu Q; Gu Y; Huang Y; Zeng Z; Tang F; Ouyang Y
    Mol Cancer; 2024 Jan; 23(1):11. PubMed ID: 38200551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian Rhythm Disruption in Hepatocellular Carcinoma Investigated by Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data.
    Huang LH; Huang CY; Liu YW; Chien PC; Hsieh TM; Liu HT; Lin HP; Wu CJ; Chuang PC; Hsieh CH
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A circadian rhythm-related biomarker for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.
    Cheng Y; Yao J; Fang Q; Chen B; Zang G
    Aging (Albany NY); 2022 Dec; 14(23):9617-9631. PubMed ID: 36455876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Diurnal Transcriptome Reveals the Reprogramming of Lung Adenocarcinoma Cells Under a Time-Restricted Feeding-Mimicking Regimen.
    Fang G; Chen Q; Li J; Lian X; Shi D
    J Nutr; 2024 Feb; 154(2):354-368. PubMed ID: 38065409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian Rhythm Disruption Promotes Lung Tumorigenesis.
    Papagiannakopoulos T; Bauer MR; Davidson SM; Heimann M; Subbaraj L; Bhutkar A; Bartlebaugh J; Vander Heiden MG; Jacks T
    Cell Metab; 2016 Aug; 24(2):324-31. PubMed ID: 27476975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma.
    Yang L; He YT; Dong S; Wei XW; Chen ZH; Zhang B; Chen WD; Yang XR; Wang F; Shang XM; Zhong WZ; Wu YL; Zhou Q
    J Immunother Cancer; 2022 Jan; 10(2):. PubMed ID: 35140113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The circadian clock circuitry deconvolutes colorectal cancer and lung adenocarcinoma heterogeneity in a dynamic time-related framework.
    Melocchi V; Cuttano R; Murgo E; Mazzoccoli G; Bianchi F
    Cancer Gene Ther; 2023 Oct; 30(10):1323-1329. PubMed ID: 37479798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma.
    Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y
    Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma.
    Zhang L; Zhang Z; Yu Z
    J Transl Med; 2019 Dec; 17(1):423. PubMed ID: 31847905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
    Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
    Front Immunol; 2021; 12():693062. PubMed ID: 34497605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
    Guo L; Li X; Liu R; Chen Y; Ren C; Du S
    Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of multiple key molecules in lung adenocarcinoma identifies prognostic and immunotherapeutic relevant gene signatures.
    Wu Q; Wang L; Wei H; Li B; Yang J; Wang Z; Xu J; Zhou YL; Zhang B
    Int Immunopharmacol; 2020 Jun; 83():106477. PubMed ID: 32278127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis.
    Xian H; Li Y; Zou B; Chen Y; Yin H; Li X; Pan Y
    BMC Cancer; 2022 Jan; 22(1):107. PubMed ID: 35078435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
    Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.